Abstract
KCNQ genes encode a growing family of six transmembrane domains, single port-loop, K+ channel alpha -subunits that have a wide range of physiological correlates. KCNQ 1 (KVLTQ 1) is co-assembled with the product of the KCNE 1 (minimal K (+) -channel protein) gene in the heart to form a cardiac-delayed rectifier-like K+ current. Mutations in this channel can cause one form of inherited Long QT syndrome (LQT 1), as well as being associated with a form of deafness. KCNQ 1 can also co-assemble with KCNE3, and may be the molecular correlate of the cyclic AMP-regulated K+ current present in colonic crypt cells. KCNQ2 and KCNQ3 heteromultimers are thought to underlie the M-current; mutations in these genes may cause an inherited form of juvenile epilepsy. The KCNQ4 gene is thought to encode the molecular correlate of the I-K.n in outer hair cells of the cochlea and I-K.L in Type I hair calls of the vestibular apparatus, mutations in which lead to a form of inherited deafness. The recently identified KCNQ5 gene is expressed in brain and skeletal muscle. and can co-assemble with KCNQ3. suggesting it may also play a role in the M-current heterogeneity This review will set this family of K - channels amongst the other known families. It will highlight the genes, physiology, pharmacology. and pathophysiology of this recently discovered, but important, family of K+ channels. (C) 2001 Elsevier Science Inc. All rights reserved.
| Original language | English |
|---|---|
| Pages (from-to) | 1 - 19 |
| Number of pages | 19 |
| Journal | Pharmacology and Therapeutics |
| Volume | 90 |
| Issue number | 1 |
| Publication status | Published - 2001 |